Pembrolizumab (Keytruda) — everything you need to know about cost, insurance, savings, and what you might pay in 2025
1. What is Keytruda?
-
Generic name: pembrolizumab
-
Type: Immune checkpoint inhibitor (anti-PD-1 antibody)
-
Indications: Lung cancer, melanoma, head & neck cancers, colorectal cancer, and more
-
Administration: Intravenous infusion (~30 minutes) at doses of 200 mg every 3 weeks or 400 mg every 6 weeks.
📖 Official FDA drug information
2. Keytruda’s List Price per Infusion (USA 2025)
Dose / Schedule | Price per Infusion (List / ASP) |
---|---|
200 mg every 3 weeks | ≈ US$11,564.16 (Medical News Today) |
400 mg every 6 weeks | ≈ US$23,590.88 (Keytruda official site) |
💡 According to CMS (Medicare ASP Pricing Data), the average sales price (ASP) in July–Sept 2025 is ~$58.56 per mg, giving ~$11,712.40 per 200 mg infusion.
⚠️ Note: List price ≠ what patients pay. Insurance and assistance programs significantly reduce out-of-pocket costs.
3. What Patients Actually Pay (Out-of-Pocket)
Your real cost depends on insurance and eligibility:
-
Commercial insurance: $0 – $375 per infusion (Merck Co-pay Assistance)
-
Medicare Advantage: $0 – $1,325 per infusion
-
Traditional Medicare (no Medigap): $1,300 – $2,100 per infusion (Drugs.com Medicare Coverage)
-
Medicaid: $4 – $8 per infusion, depending on state (Medicaid.gov)
📊 A Serif Health Transparency Study shows commercial insurers sometimes pay $12,000–$30,000+ depending on provider & location.
4. Factors That Affect Keytruda Pricing
-
Dosage & frequency: FDA dosing guide
-
Hospital vs outpatient clinic: Hospitals often add facility fees
-
Insurance plan design: Deductibles, coinsurance, out-of-network charges
-
Additional medical costs: Labs, infusion fees, monitoring
-
Regional variation: Negotiated prices differ by state/provider
5. Insurance, Medicare & Medicaid Coverage
-
Medicare Part B: Covers Keytruda for approved cancer indications. Patients usually pay 20% coinsurance unless they have Medigap (Medicare.gov).
-
Medicare Advantage (Part C): Out-of-pocket costs vary by plan formulary.
-
Medigap: Helps reduce coinsurance or deductible burdens.
-
Medicaid: Often the most affordable, sometimes as low as $4 per dose (Medicaid pharmacy benefits).
6. Financial Assistance & Savings Programs
-
Merck Access Program – support for uninsured/underinsured patients
-
Merck Co-pay Assistance – eligible patients may pay as little as $25 per infusion
-
GoodRx Keytruda pricing tool
-
HealthWell Foundation – nonprofit support for cancer patients
7. New Developments (2025)
-
Subcutaneous Keytruda: Merck plans U.S. launch in October 2025, making administration faster (Reuters).
-
Drug price negotiations: Starting 2026, Keytruda will be part of the Inflation Reduction Act’s Medicare drug price negotiations, potentially lowering costs by 2028 (Reuters).
8. Frequently Asked Questions (FAQs)
Q1: Is there a generic Keytruda?
A: No. There are currently no FDA-approved biosimilars for pembrolizumab (FDA biosimilars info).
Q2: How much does Keytruda cost with Medicare?
A: About $11,500 list price per 200 mg infusion, but patients typically pay $1,300–$2,100 depending on plan coverage (Medical News Today).
Q3: What if I have no insurance?
A: Expect full list price ($11,000–$23,000+ per infusion) unless you qualify for Merck’s patient assistance.
Q4: Does Medicaid cover Keytruda?
A: Yes, at very low out-of-pocket cost (usually $4–$8) depending on state (Medicaid state profiles).
Q5: How long will I need Keytruda?
A: Treatment duration varies; many patients receive infusions for up to 2 years, depending on cancer type and response.
9. High-Value SEO Keywords
-
Keytruda cost per infusion 2025
-
Keytruda price USA insurance
-
Pembrolizumab price guide
-
Keytruda Medicare coverage cost
-
Keytruda co-pay assistance 2025
-
Immunotherapy cancer drug cost
10. Conclusion
Keytruda is a groundbreaking treatment for many cancers but comes with very high costs in the USA—$11,000+ per infusion at list price.
✅ The good news: most patients do not pay full price. With insurance, Medicare/Medicaid, co-pay support, and nonprofit aid, many can access treatment at significantly lower out-of-pocket cost.
📌 If you or a loved one is prescribed Keytruda:
-
Talk to your oncologist about insurance coverage
-
Ask your provider to check Merck Access Programs
-
Compare state Medicaid options
-
Stay updated about 2025–2028 pricing changes
Add a Comment